Company Filing History:
Years Active: 2012
Title: Aurora Martínez Ruiz: Innovator in the Treatment of Hyperphenylalaninemia
Introduction
Aurora Martínez Ruiz is a prominent inventor based in Zaragoza, Spain. She has made significant contributions to the field of pharmacology, particularly in the treatment of metabolic disorders. Her innovative work focuses on developing compositions that address hyperphenylalaninemia, a condition that can lead to serious health issues if left untreated.
Latest Patents
Aurora holds 1 patent for her invention titled "Compositions for the treatment of hyperphenylalaninemia." This patent relates to the use of specific compounds that act as pharmacological chaperones. These compounds have a stabilizing effect on the phenylalanine hydroxylase (PAH) enzyme, which is crucial for the prophylaxis and treatment of hyperphenylalaninemia (HPA) and phenylketonuria (PKU). The invention also encompasses pharmaceutical compositions containing these compounds and methods for treating HPA and related conditions.
Career Highlights
Aurora is affiliated with the Universidad de Zaragoza, where she conducts her research and development work. Her academic background and expertise in pharmacology have positioned her as a key figure in her field. She is dedicated to advancing treatments that improve the quality of life for individuals affected by metabolic disorders.
Collaborations
Aurora has collaborated with notable colleagues, including Ángel Pey Rodríguez and Javier Sancho Sanz. These partnerships have enhanced her research efforts and contributed to the successful development of her innovative treatments.
Conclusion
Aurora Martínez Ruiz is a trailblazer in the field of pharmacology, with her groundbreaking work on hyperphenylalaninemia paving the way for new treatment options. Her dedication to research and collaboration exemplifies the spirit of innovation in addressing complex health challenges.